CSPC PHARMA News

CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - HIGHLY SELECTIVE MAT2A INHIBITOR (SYH2039) OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S.

Apr 26 04:31 ET

CSPC PHARMA: NOTIFICATION LETTER TO NON-REGISTERED HOLDER AND REQUEST FORM

Apr 25 10:25 ET

CSPC PHARMA: NOTIFICATION LETTER TO SHAREHOLDER AND CHANGE REQUEST FORM

Apr 25 10:25 ET

CSPC PHARMA: LETTER TO NEW REGISTERED SHAREHOLDERS AND REPLY FORM

Apr 25 10:24 ET

CSPC PHARMA: PROXY FORM FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON 28 MAY 2024 AT 10:00 A.M. (AND AT ANY ADJOURNMENT THEREOF)

Apr 25 10:23 ET

CSPC PHARMA: 2023 Environmental, Social and Governance Report

Apr 25 10:20 ET

CSPC PHARMA: NEXT DAY DISCLOSURES RETURNS

Apr 22 06:17 ET

CSPC PHARMA: NEXT DAY DISCLOSURES RETURNS

Apr 19 05:51 ET

CSPC PHARMA: NEXT DAY DISCLOSURES RETURNS

Apr 18 05:45 ET

CSPC PHARMA: NEXT DAY DISCLOSURES RETURNS

Apr 17 06:22 ET

CSPC PHARMA: NEXT DAY DISCLOSURES RETURNS

Apr 16 05:59 ET

CSPC PHARMA: NEXT DAY DISCLOSURES RETURNS

Apr 15 05:28 ET

CSPC PHARMA: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2024

Apr 2 05:38 ET

CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - SEMAGLUTIDE INJECTION FOR OVERWEIGHT/OBESITY INDICATION OBTAINS CLINICAL TRIAL APPROVAL

Mar 25 05:07 ET

CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - DAPAGLIFLOZIN TABLETS OBTAINS DRUG REGISTRATION APPROVAL

Mar 22 04:31 ET

CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - ANTIBODY-DRUG CONJUGATE SYS6023 OBTAINS CLINICAL TRIAL APPROVAL

Mar 20 05:25 ET

CSPC PHARMA: CASH DIVIDEND ANNOUNCEMENT FOR EQUITY ISSUER

Mar 20 05:22 ET

CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - HIGHLY SELECTIVE MAT2A INHIBITOR (SYH2039)OBTAINS CLINICAL TRIAL APPROVAL

Mar 18 06:08 ET

CSPC PHARMA: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 29 FEBRUARY 2024

Mar 1 03:47 ET

CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - INDICATION FOR ACUTE ISCHEMIC STROKE OF MINGFULE (RECOMBINANT HUMAN TNK TISSUE-TYPE PLASMINOGEN ACTIVATOR FOR INJECTION) OBTAINS MARKETING APPROVAL

Feb 4 23:15 ET